| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |